TY - JOUR
T1 - Reducing overtreatment
T2 - A comparison of lymph node assessment strategies for endometrial cancer
AU - Sinno, Abdulrahman K.
AU - Peijnenburg, Elizabeth
AU - Fader, Amanda N.
AU - Temkin, Sarah M.
AU - Stone, Rebecca
AU - Levinson, Kimberly
AU - Murdock, Tricia
AU - Tanner, Edward
PY - 2016/11/1
Y1 - 2016/11/1
N2 - Objectives To compare the utility of three lymph node (LN) assessment strategies to identify lymphatic metastases while minimizing complete lymphadenectomy rates in women with low-grade endometrial cancer (EC). Methods: Using our institutional standard protocol (SP), patients with complex atypical hyperplasia (CAH) or grade 1/2 EC underwent sentinel lymph node (SLN) mapping, hysterectomy, and intraoperative frozen section (FS). Lymphadenectomy was performed if high-risk uterine features were identified on FS. Utilizing SP data, two alternative strategies were applied: a Universal FS Strategy (UFS), omitting SLN mapping and performing lymphadenectomy based on FS results, and a SLN-Restrictive FS Strategy (SLN-RFS) in which FS and lymphadenectomy are performed only if bilateral SLN mapping fails. Results Of 114 patients managed on the SP, SLNs were identified in 86%, with lymphatic metastases detected in eight patients. Six patients recurred after a median follow up of 15 months. Most (83%) developed in those who had a negative systematic lymphadenectomy (n = 4; mean LNs: 18) or no lymphadenectomy indication. When applying the alternative lymphatic assessment strategies, the SLN-RFS approach would theoretically result in lower lymphadenectomy rates compared to both the SP and the alternative UFS strategies (9.2% versus 36.8% and 36.8%, respectively; p = 0.004), without a reduction in detection of LN metastases (8/8 versus 8/8 and 5/8, respectively). Conclusion In this modeling analysis, an operative strategy omitting universal frozen section and restricting its use to cases with failed SLN mapping may result in lower lymphadenectomy rates and reduce the risk of overtreatment without compromising oncologic outcome for patients with EC.
AB - Objectives To compare the utility of three lymph node (LN) assessment strategies to identify lymphatic metastases while minimizing complete lymphadenectomy rates in women with low-grade endometrial cancer (EC). Methods: Using our institutional standard protocol (SP), patients with complex atypical hyperplasia (CAH) or grade 1/2 EC underwent sentinel lymph node (SLN) mapping, hysterectomy, and intraoperative frozen section (FS). Lymphadenectomy was performed if high-risk uterine features were identified on FS. Utilizing SP data, two alternative strategies were applied: a Universal FS Strategy (UFS), omitting SLN mapping and performing lymphadenectomy based on FS results, and a SLN-Restrictive FS Strategy (SLN-RFS) in which FS and lymphadenectomy are performed only if bilateral SLN mapping fails. Results Of 114 patients managed on the SP, SLNs were identified in 86%, with lymphatic metastases detected in eight patients. Six patients recurred after a median follow up of 15 months. Most (83%) developed in those who had a negative systematic lymphadenectomy (n = 4; mean LNs: 18) or no lymphadenectomy indication. When applying the alternative lymphatic assessment strategies, the SLN-RFS approach would theoretically result in lower lymphadenectomy rates compared to both the SP and the alternative UFS strategies (9.2% versus 36.8% and 36.8%, respectively; p = 0.004), without a reduction in detection of LN metastases (8/8 versus 8/8 and 5/8, respectively). Conclusion In this modeling analysis, an operative strategy omitting universal frozen section and restricting its use to cases with failed SLN mapping may result in lower lymphadenectomy rates and reduce the risk of overtreatment without compromising oncologic outcome for patients with EC.
UR - http://www.scopus.com/inward/record.url?scp=84994115535&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84994115535&partnerID=8YFLogxK
U2 - 10.1016/j.ygyno.2016.08.323
DO - 10.1016/j.ygyno.2016.08.323
M3 - Article
C2 - 27568279
AN - SCOPUS:84994115535
SN - 0090-8258
VL - 143
SP - 281
EP - 286
JO - Gynecologic Oncology
JF - Gynecologic Oncology
IS - 2
ER -